Renal Phenotype in Mice Lacking the Kir5.1 (Kcnj16) K Channel Subunit

Total Page:16

File Type:pdf, Size:1020Kb

Renal Phenotype in Mice Lacking the Kir5.1 (Kcnj16) K Channel Subunit Renal phenotype in mice lacking the Kir5.1 (Kcnj16) K+ channel subunit contrasts with that observed in SeSAME/EAST syndrome Marc Paulaisa,b,1, May Bloch-Faurea,b, Nicolas Picarda,b, Thibaut Jacquesb,c, Suresh Krishna Ramakrishnana,b, Mathilde Kecka,b, Fabien Soheta,b, Dominique Eladaria,b,c,d, Pascal Houilliera,b,c,d, Stéphane Lourdela,b, Jacques Teulona,b, and Stephen J. Tuckere aUniversité Pierre et Marie Curie Paris 6, Université Paris 5, and Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche en Santé 872, 75006 Paris, France; bCentre National de la Recherche Scientifique, Équipes de Recherche Labellisées 7226, Genomics Physiology, and Renal Physiopathology Laboratory, Centre de Recherche des Cordeliers, 75270 Paris 6, France; cFaculty of Medicine, Université Paris–Descartes, 75006 Paris, France; dAssistance Publique–Hôpitaux de Paris, Hôpital Européen Georges Pompidou, 75015 Paris, France; and eClarendon Laboratory and Department of Physics, University of Oxford, Oxford OX1 3PU, United Kingdom Edited by Maurice B. Burg, National Heart, Lung, and Blood Institute, Bethesda, MD, and approved May 9, 2011 (received for review January 31, 2011) The heteromeric inwardly rectifying Kir4.1/Kir5.1 K+ channel underlies encodes the Kir4.1 subunit, underlie SeSAME/EAST syndrome, the basolateral K+ conductance in the distal nephron and is extremely a rare disorder in which patients experience neurological and sensitive to inhibition by intracellular pH. The functional importance renal symptoms (11, 12). In the kidney, it is thought that these of Kir4.1/Kir5.1 in renal ion transport has recently been highlighted by loss-of-function mutations in Kir4.1 impair the function of het- mutations in the human Kir4.1 gene (KCNJ10) that result in seizures, eromeric Kir4.1/Kir5.1 channels (13, 14), thereby dramatically sensorineural deafness, ataxia, mental retardation, and electrolyte impairing salt reuptake from the DCT, and increasing down- imbalance (SeSAME)/epilepsy, ataxia, sensorineural deafness, and re- stream K+ and H+ secretion. This results in a Gitelman-like nal tubulopathy (EAST) syndrome, a complex disorder that includes syndrome, characterized by salt wasting, hypocalciuria, hypo- salt wasting and hypokalemic alkalosis. Here, we investigated the role magnesaemia, and hypokalemic metabolic alkalosis (11, 12, 15). of the Kir5.1 subunit in mice with a targeted disruption of the Kir5.1 The basolateral location of Kir4.1/Kir5.1 channels obviously −/− gene (Kcnj16). The Kir5.1 mice displayed hypokalemic, hyper- suggests a role for these channels in maintenance of the baso- chloremic metabolic acidosis with hypercalciuria. The short-term lateral membrane potential, and in the “recycling” across the responses to hydrochlorothiazide, an inhibitor of ion transport in basolateral membrane of any K+ that enters the cell via the the distal convoluted tubule (DCT), were also exaggerated, indicating basolateral Na+/K+ ATPase. The recycling of K+ is a crucial step excessive renal Na+ absorption in this segment. Furthermore, chronic for sustained transepithelial Na+ reabsorption. However, in the treatment with hydrochlorothiazide normalized urinary excretion of DCT of patients with seizures, sensorineural deafness, ataxia, Na+ and Ca2+, and abolished acidosis in Kir5.1−/− mice. Finally, in con- mental retardation, and electrolyte imbalance (SeSAME)/epilepsy, trast to WT mice, electrophysiological recording of K+ channels in the ataxia, sensorineural deafness, and renal tubulopathy (EAST) −/− DCT basolateral membrane of Kir5.1 mice revealed that, even syndrome, this K+ recycling seems to be altered. though Kir5.1 is absent, there is an increased K+ conductance caused The expression of Kir5.1 alone does not produce detectable by the decreased pH sensitivity of the remaining homomeric Kir4.1 K+ currents in most recombinant expression systems (16). In- channels. In conclusion, disruption of Kcnj16 induces a severe renal stead, this “silent” subunit appears to heteromultimerize with phenotype that, apart from hypokalemia, is the opposite of the phe- Kir4.1 to produce novel Kir4.1/Kir5.1 channels (17–19) that have notype seen in SeSAME/EAST syndrome. These results highlight the an extreme sensitivity to intracellular pH (pHi) within the physi- important role that Kir5.1 plays as a pH-sensitive regulator of salt ological range (i.e., pKa of 7.4) (18, 20, 21). By contrast, homo- PHYSIOLOGY transport in the DCT, and the implication of these results for the meric Kir4.1 channels are only mildly sensitive to pHi (pKa, 6.0). correct genetic diagnosis of renal tubulopathies is discussed. This therefore raises the important question of how Kir5.1 con- tributes to renal ion transport and the role of these highly pH- kidney | homeostasis | acid–base balance sensitive Kir4.1/Kir5.1 channels in this process. The present study addresses this issue by using a recently + channels play critical roles in renal tubular transport created strain of mice in which the Kir5.1(Kcnj16) gene has been + deleted (22). We show that deletion of this subunit results in a K functions directly by providing a secretory pathway for K + or indirectly by controlling membrane voltage and K+ recycling pHi-insensitive, highly active K conductance in the DCT baso- across the plasma membrane (1). Recent genetic and functional lateral membrane, and a severe renal phenotype characterized by studies have shown that loss of renal K+ channel activity not only hypokalemic metabolic acidosis with hypercalciuria. Thus, instead has an impact on K+ balance, but also affects other ion transport of producing an effect similar to SeSAME/EAST syndrome mutations in Kir4.1, inactivation of Kir5.1 reduces the pH sen- systems and the regulation of the acid–base balance. For in- i sitivity of the DCT basolateral K+ conductance and produces a stance, it has been clearly established that inherited mutations of mirror-image phenotype to SeSAME/EAST syndrome by increasing the human KCNJ1 gene underlie type II Bartter syndrome, a + the mean basolateral K conductance in the distal nephron. severe disorder involving renal salt wasting and hypokalemic metabolic alkalosis (2). Likewise, inactivation of the Kcnk5 gene encoding the acid- and volume-sensitive TASK2 K+ channel − Author contributions: M.P. and J.T. designed research; M.P., M.B.-F., N.P., T.J., S.K.R., M.K., induces renal HCO3 loss and metabolic acidosis in mice (3). F.S., P.H., S.L., and J.T. performed research; M.P., N.P., T.J., S.L., and J.T. analyzed data; and The cortical thick ascending limb (4, 5), distal convoluted tu- M.P., D.E., J.T., and S.J.T. wrote the paper. bule (DCT) (6, 7), and cortical collecting duct (CCD) principal The authors declare no conflict of interest. + cells (8, 9) are endowed with K channels displaying properties This article is a PNAS Direct Submission. + identical to inwardly rectifying heteromeric Kir4.1/Kir5.1 K 1To whom correspondence should be addressed. E-mail: [email protected]. channels (10). Recent studies have reported that rare homozy- This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. gous missense mutations of the human KCNJ10 gene, which 1073/pnas.1101400108/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1101400108 PNAS | June 21, 2011 | vol. 108 | no. 25 | 10361–10366 Downloaded by guest on October 1, 2021 Results −/− Clinical Parameters of Kir5.1 Mice. There was no obvious dif- ference in the survival or gross physical appearance between − − Kir5.1+/+ and Kir5.1 / mice maintained on a control diet, except − − for an approximately 15% lower body weight of the Kir5.1 / − − mice (P < 0.0001; Table 1). Kir5.1 / mice were slightly poly- dipsic, and exhibited polyuria and correspondingly lower urine osmolality. However, both groups of mice adapted normally to 24 h water restriction (Fig. 1), indicating that the urine- − − concentrating ability of Kir5.1 / mice is not impaired. Further- − − more, the hematocrit level of Kir5.1 / mice was not increased − − (45.7 ± 1.42% vs. 45.5 ± 1.13% for Kir5.1+/+ and Kir5.1 / mice, respectively; P = 0.4), indicating the absence of dehydration. Fig. 1. Urine-concentrating ability of Kir5.1+/+ and Kir5.1−/− mice. Daily di- uresis (A) and urine osmolality (B)ofKir5.1+/+ (□) and Kir5.1−/− (■) mice −/− Kir5.1 Mice Display Metabolic Acidosis and Hypokalemia. Blood maintained in metabolic cages were first measured while the mice had −/− and plasma analyses revealed that Kir5.1 mice had metabolic free access to demineralized water (+H2O), and then after a 24-h period of water deprivation (−H2O). Weight loss induced by water deprivation aver- hyperchloremic acidosis (Table 1). However, despite this acidosis, − − + aged 7% and 9% for Kir5.1+/+ and Kir5.1 / mice, respectively. Water depri- urinary NH4 excretion was not increased (81 ± 3.5 mmol/mmol −/− vation tests showed that both groups of mice had similar urine-concentrating creatinine in 10 Kir5.1 mice vs. 99 ± 5.2 mmol/mmol creatinine in +/+ −/− +/+ abilities. Values are mean values for 10 Kir5.1 and eight Kir5.1 mice. fi − − 11 Kir5.1 mice). Also, glomerular ltration rates were similar in Error bars represent SEM when larger than symbols. *P < 0.05, Kir5.1 / versus +/+ −/− Kir5.1 mice (308 ± 43 μL/min; n = 11) and Kir5.1 mice (272 Kir5.1+/+ mice. ± 35 μL/min; n =7;P = 0.54), indicating the absence of chronic − − renal failure. Our data therefore clearly show that Kir5.1 / mice have renal tubular acidosis. However, this may also be associated No Alteration in the Responses to Furosemide and Amiloride in − − −/− with a respiratory component because the Kir5.1 / mice do not Kir5.1 Mice. Expression of Kir5.1 is also seen in the TAL and display the expected compensatory decrease in blood PCO2 (Table DCT cells, as well as in CCD principal cells, where it coassem- 1), an effect that would be consistent with the respiratory phe- bles with Kir4.1 to form Kir4.1/Kir5.1 channels in the basolateral notype recently reported in these mice (22).
Recommended publications
  • Reframing Psychiatry for Precision Medicine
    Reframing Psychiatry for Precision Medicine Elizabeth B Torres 1,2,3* 1 Rutgers University Department of Psychology; [email protected] 2 Rutgers University Center for Cognitive Science (RUCCS) 3 Rutgers University Computer Science, Center for Biomedicine Imaging and Modelling (CBIM) * Correspondence: [email protected]; Tel.: (011) +858-445-8909 (E.B.T) Supplementary Material Sample Psychological criteria that sidelines sensory motor issues in autism: The ADOS-2 manual [1, 2], under the “Guidelines for Selecting a Module” section states (emphasis added): “Note that the ADOS-2 was developed for and standardized using populations of children and adults without significant sensory and motor impairments. Standardized use of any ADOS-2 module presumes that the individual can walk independently and is free of visual or hearing impairments that could potentially interfere with use of the materials or participation in specific tasks.” Sample Psychiatric criteria from the DSM-5 [3] that does not include sensory-motor issues: A. Persistent deficits in social communication and social interaction across multiple contexts, as manifested by the following, currently or by history (examples are illustrative, not exhaustive, see text): 1. Deficits in social-emotional reciprocity, ranging, for example, from abnormal social approach and failure of normal back-and-forth conversation; to reduced sharing of interests, emotions, or affect; to failure to initiate or respond to social interactions. 2. Deficits in nonverbal communicative behaviors used for social interaction, ranging, for example, from poorly integrated verbal and nonverbal communication; to abnormalities in eye contact and body language or deficits in understanding and use of gestures; to a total lack of facial expressions and nonverbal communication.
    [Show full text]
  • The Mineralocorticoid Receptor Leads to Increased Expression of EGFR
    www.nature.com/scientificreports OPEN The mineralocorticoid receptor leads to increased expression of EGFR and T‑type calcium channels that support HL‑1 cell hypertrophy Katharina Stroedecke1,2, Sandra Meinel1,2, Fritz Markwardt1, Udo Kloeckner1, Nicole Straetz1, Katja Quarch1, Barbara Schreier1, Michael Kopf1, Michael Gekle1 & Claudia Grossmann1* The EGF receptor (EGFR) has been extensively studied in tumor biology and recently a role in cardiovascular pathophysiology was suggested. The mineralocorticoid receptor (MR) is an important efector of the renin–angiotensin–aldosterone‑system and elicits pathophysiological efects in the cardiovascular system; however, the underlying molecular mechanisms are unclear. Our aim was to investigate the importance of EGFR for MR‑mediated cardiovascular pathophysiology because MR is known to induce EGFR expression. We identifed a SNP within the EGFR promoter that modulates MR‑induced EGFR expression. In RNA‑sequencing and qPCR experiments in heart tissue of EGFR KO and WT mice, changes in EGFR abundance led to diferential expression of cardiac ion channels, especially of the T‑type calcium channel CACNA1H. Accordingly, CACNA1H expression was increased in WT mice after in vivo MR activation by aldosterone but not in respective EGFR KO mice. Aldosterone‑ and EGF‑responsiveness of CACNA1H expression was confrmed in HL‑1 cells by Western blot and by measuring peak current density of T‑type calcium channels. Aldosterone‑induced CACNA1H protein expression could be abrogated by the EGFR inhibitor AG1478. Furthermore, inhibition of T‑type calcium channels with mibefradil or ML218 reduced diameter, volume and BNP levels in HL‑1 cells. In conclusion the MR regulates EGFR and CACNA1H expression, which has an efect on HL‑1 cell diameter, and the extent of this regulation seems to depend on the SNP‑216 (G/T) genotype.
    [Show full text]
  • The Chondrocyte Channelome: a Novel Ion Channel Candidate in the Pathogenesis of Pectus Deformities
    Old Dominion University ODU Digital Commons Biological Sciences Theses & Dissertations Biological Sciences Summer 2017 The Chondrocyte Channelome: A Novel Ion Channel Candidate in the Pathogenesis of Pectus Deformities Anthony J. Asmar Old Dominion University, [email protected] Follow this and additional works at: https://digitalcommons.odu.edu/biology_etds Part of the Biology Commons, Molecular Biology Commons, and the Physiology Commons Recommended Citation Asmar, Anthony J.. "The Chondrocyte Channelome: A Novel Ion Channel Candidate in the Pathogenesis of Pectus Deformities" (2017). Doctor of Philosophy (PhD), Dissertation, Biological Sciences, Old Dominion University, DOI: 10.25777/pyha-7838 https://digitalcommons.odu.edu/biology_etds/19 This Dissertation is brought to you for free and open access by the Biological Sciences at ODU Digital Commons. It has been accepted for inclusion in Biological Sciences Theses & Dissertations by an authorized administrator of ODU Digital Commons. For more information, please contact [email protected]. THE CHONDROCYTE CHANNELOME: A NOVEL ION CHANNEL CANDIDATE IN THE PATHOGENESIS OF PECTUS DEFORMITIES by Anthony J. Asmar B.S. Biology May 2010, Virginia Polytechnic Institute M.S. Biology May 2013, Old Dominion University A Dissertation Submitted to the Faculty of Old Dominion University in Partial Fulfillment of the Requirements for the Degree of DOCTOR OF PHILOSOPHY BIOMEDICAL SCIENCES OLD DOMINION UNIVERSITY August 2017 Approved by: Christopher Osgood (Co-Director) Michael Stacey (Co-Director) Lesley Greene (Member) Andrei Pakhomov (Member) Jing He (Member) ABSTRACT THE CHONDROCYTE CHANNELOME: A NOVEL ION CHANNEL CANDIDATE IN THE PATHOGENESIS OF PECTUS DEFORMITIES Anthony J. Asmar Old Dominion University, 2017 Co-Directors: Dr. Christopher Osgood Dr. Michael Stacey Costal cartilage is a type of rod-like hyaline cartilage connecting the ribs to the sternum.
    [Show full text]
  • Prevalence and Incidence of Rare Diseases: Bibliographic Data
    Number 1 | January 2019 Prevalence and incidence of rare diseases: Bibliographic data Prevalence, incidence or number of published cases listed by diseases (in alphabetical order) www.orpha.net www.orphadata.org If a range of national data is available, the average is Methodology calculated to estimate the worldwide or European prevalence or incidence. When a range of data sources is available, the most Orphanet carries out a systematic survey of literature in recent data source that meets a certain number of quality order to estimate the prevalence and incidence of rare criteria is favoured (registries, meta-analyses, diseases. This study aims to collect new data regarding population-based studies, large cohorts studies). point prevalence, birth prevalence and incidence, and to update already published data according to new For congenital diseases, the prevalence is estimated, so scientific studies or other available data. that: Prevalence = birth prevalence x (patient life This data is presented in the following reports published expectancy/general population life expectancy). biannually: When only incidence data is documented, the prevalence is estimated when possible, so that : • Prevalence, incidence or number of published cases listed by diseases (in alphabetical order); Prevalence = incidence x disease mean duration. • Diseases listed by decreasing prevalence, incidence When neither prevalence nor incidence data is available, or number of published cases; which is the case for very rare diseases, the number of cases or families documented in the medical literature is Data collection provided. A number of different sources are used : Limitations of the study • Registries (RARECARE, EUROCAT, etc) ; The prevalence and incidence data presented in this report are only estimations and cannot be considered to • National/international health institutes and agencies be absolutely correct.
    [Show full text]
  • Orphanet Report Series Rare Diseases Collection
    Marche des Maladies Rares – Alliance Maladies Rares Orphanet Report Series Rare Diseases collection DecemberOctober 2013 2009 List of rare diseases and synonyms Listed in alphabetical order www.orpha.net 20102206 Rare diseases listed in alphabetical order ORPHA ORPHA ORPHA Disease name Disease name Disease name Number Number Number 289157 1-alpha-hydroxylase deficiency 309127 3-hydroxyacyl-CoA dehydrogenase 228384 5q14.3 microdeletion syndrome deficiency 293948 1p21.3 microdeletion syndrome 314655 5q31.3 microdeletion syndrome 939 3-hydroxyisobutyric aciduria 1606 1p36 deletion syndrome 228415 5q35 microduplication syndrome 2616 3M syndrome 250989 1q21.1 microdeletion syndrome 96125 6p subtelomeric deletion syndrome 2616 3-M syndrome 250994 1q21.1 microduplication syndrome 251046 6p22 microdeletion syndrome 293843 3MC syndrome 250999 1q41q42 microdeletion syndrome 96125 6p25 microdeletion syndrome 6 3-methylcrotonylglycinuria 250999 1q41-q42 microdeletion syndrome 99135 6-phosphogluconate dehydrogenase 67046 3-methylglutaconic aciduria type 1 deficiency 238769 1q44 microdeletion syndrome 111 3-methylglutaconic aciduria type 2 13 6-pyruvoyl-tetrahydropterin synthase 976 2,8 dihydroxyadenine urolithiasis deficiency 67047 3-methylglutaconic aciduria type 3 869 2A syndrome 75857 6q terminal deletion 67048 3-methylglutaconic aciduria type 4 79154 2-aminoadipic 2-oxoadipic aciduria 171829 6q16 deletion syndrome 66634 3-methylglutaconic aciduria type 5 19 2-hydroxyglutaric acidemia 251056 6q25 microdeletion syndrome 352328 3-methylglutaconic
    [Show full text]
  • Ion Channels
    UC Davis UC Davis Previously Published Works Title THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels. Permalink https://escholarship.org/uc/item/1442g5hg Journal British journal of pharmacology, 176 Suppl 1(S1) ISSN 0007-1188 Authors Alexander, Stephen PH Mathie, Alistair Peters, John A et al. Publication Date 2019-12-01 DOI 10.1111/bph.14749 License https://creativecommons.org/licenses/by/4.0/ 4.0 Peer reviewed eScholarship.org Powered by the California Digital Library University of California S.P.H. Alexander et al. The Concise Guide to PHARMACOLOGY 2019/20: Ion channels. British Journal of Pharmacology (2019) 176, S142–S228 THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels Stephen PH Alexander1 , Alistair Mathie2 ,JohnAPeters3 , Emma L Veale2 , Jörg Striessnig4 , Eamonn Kelly5, Jane F Armstrong6 , Elena Faccenda6 ,SimonDHarding6 ,AdamJPawson6 , Joanna L Sharman6 , Christopher Southan6 , Jamie A Davies6 and CGTP Collaborators 1School of Life Sciences, University of Nottingham Medical School, Nottingham, NG7 2UH, UK 2Medway School of Pharmacy, The Universities of Greenwich and Kent at Medway, Anson Building, Central Avenue, Chatham Maritime, Chatham, Kent, ME4 4TB, UK 3Neuroscience Division, Medical Education Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK 4Pharmacology and Toxicology, Institute of Pharmacy, University of Innsbruck, A-6020 Innsbruck, Austria 5School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, BS8 1TD, UK 6Centre for Discovery Brain Science, University of Edinburgh, Edinburgh, EH8 9XD, UK Abstract The Concise Guide to PHARMACOLOGY 2019/20 is the fourth in this series of biennial publications. The Concise Guide provides concise overviews of the key properties of nearly 1800 human drug targets with an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties.
    [Show full text]
  • Altered Physiological Functions and Ion Currents in Atrial Fibroblasts From
    Physiological Reports ISSN 2051-817X ORIGINAL RESEARCH Altered physiological functions and ion currents in atrial fibroblasts from patients with chronic atrial fibrillation Claire Poulet1, Stephan Kunzel€ 1, Edgar Buttner€ 1, Diana Lindner2, Dirk Westermann2 & Ursula Ravens1 1 Department of Pharmacology and Toxicology, Medical Faculty Carl-Gustav-Carus, TU Dresden, Dresden, Germany 2 Department of General and Interventional Cardiology, University Heart Center Hamburg Eppendorf, Hamburg, Germany Keywords Abstract Atrial fibrillation, electrophysiology, fibroblasts. The contribution of human atrial fibroblasts to cardiac physiology and patho- physiology is poorly understood. Fibroblasts may contribute to arrhythmogen- Correspondence esis through fibrosis, or by directly altering electrical activity in Claire Poulet, Imperial College London, Imperial cardiomyocytes. The objective of our study was to uncover phenotypic differ- Centre for Translational and Experimental ences between cells from patients in sinus rhythm (SR) and chronic atrial fib- Medicine, Hammersmith Campus, Du Cane rillation (AF), with special emphasis on electrophysiological properties. We Road, London W12 0NN, UK isolated fibroblasts from human right atrial tissue for patch-clamp experi- Tel: +44 207 594 2738 Fax: +44 207 594 3653 ments, proliferation, migration, and differentiation assays, and gene expression E-mail: [email protected] profiling. In culture, proliferation and migration of AF fibroblasts were strongly impaired but differentiation into myofibroblasts was increased. This Present Addresses was associated with a higher number of AF fibroblasts expressing functional Claire Poulet, Imperial College London, Nav1.5 channels. Strikingly Na+ currents were considerably larger in AF cells. National Heart and Lung Institute, London, UK Blocking Na+ channels in culture with tetrodotoxin did not affect prolifera- tion, migration, or differentiation in neither SR nor AF cells.
    [Show full text]
  • Dendrites and Disease Daniel Johnston, Andreas Frick, and Nicholas Poolos
    OUP-FIRST UNCORRECTED PROOF, October 5, 2015 Chapter 24 Dendrites and disease Daniel Johnston, Andreas Frick, and Nicholas Poolos Summary While the functional properties of dendrites in the normal brain are the main focus of this book, there is a long history of research related to changes in dendrites that are associated with certain neurological, psychiatric, and developmental disorders. Much of this research has documented morphological changes in dendritic structure, but a significant increase in work has appeared since the second edition of this book in which changes in dendritic function have been described. In this chapter we briefly review some of the research relating structural changes in dendrites to disease, sufficient to provide a beginning reference source for readers interested in pursuing the subject further. The bulk of this chapter, however, will focus on the current state of knowledge related to dendritic “channelopathies.” These are defined as genetic or acquired defects in the normal func- tion or expression of ion channels (with a focus on voltage-gated ion channels) that are known to regulate how neuronal dendrites process and store information. The most specific and detailed information is available for epilepsy, which will be discussed at some length, but other data will be presented for certain neurodevelopmental disorders (e.g., autism, fragile X syndrome) and dis- eases of the adult and aging brain. Based on our knowledge of the normal properties of dendrites, we provide a framework for understanding how dendritic channelopathies can influence synaptic integration and plasticity and thus form the basis of abnormal brain function. Introduction Abnormalities in dendritic structure are a characteristic feature of many brain disorders.
    [Show full text]
  • Dimethylation of Histone 3 Lysine 9 Is Sensitive to the Epileptic Activity
    1368 MOLECULAR MEDICINE REPORTS 17: 1368-1374, 2018 Dimethylation of Histone 3 Lysine 9 is sensitive to the epileptic activity, and affects the transcriptional regulation of the potassium channel Kcnj10 gene in epileptic rats SHAO-PING ZHANG1,2*, MAN ZHANG1*, HONG TAO1, YAN LUO1, TAO HE3, CHUN-HUI WANG3, XIAO-CHENG LI3, LING CHEN1,3, LIN-NA ZHANG1, TAO SUN2 and QI-KUAN HU1-3 1Department of Physiology; 2Ningxia Key Laboratory of Cerebrocranial Diseases, Incubation Base of National Key Laboratory, Ningxia Medical University; 3General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China Received February 18, 2017; Accepted September 13, 2017 DOI: 10.3892/mmr.2017.7942 Abstract. Potassium channels can be affected by epileptic G9a by 2-(Hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-6,7-di- seizures and serve a crucial role in the pathophysiology of methoxy-N-(1-(phenyl-methyl)-4-piperidinyl)-4-quinazolinamine epilepsy. Dimethylation of histone 3 lysine 9 (H3K9me2) and tri-hydrochloride hydrate (bix01294) resulted in upregulation its enzyme euchromatic histone-lysine N-methyltransferase 2 of the expression of Kir4.1 proteins. The present study demon- (G9a) are the major epigenetic modulators and are associated strated that H3K9me2 and G9a are sensitive to epileptic seizure with gene silencing. Insight into whether H3K9me2 and G9a activity during the acute phase of epilepsy and can affect the can respond to epileptic seizures and regulate expression of transcriptional regulation of the Kcnj10 channel. genes encoding potassium channels is the main purpose of the present study. A total of 16 subtypes of potassium channel Introduction genes in pilocarpine-modelled epileptic rats were screened by reverse transcription-quantitative polymerase chain reac- Epilepsies are disorders of neuronal excitability, characterized tion, and it was determined that the expression ATP-sensitive by spontaneous and recurrent seizures.
    [Show full text]
  • Pflugers Final
    CORE Metadata, citation and similar papers at core.ac.uk Provided by Serveur académique lausannois A comprehensive analysis of gene expression profiles in distal parts of the mouse renal tubule. Sylvain Pradervand2, Annie Mercier Zuber1, Gabriel Centeno1, Olivier Bonny1,3,4 and Dmitri Firsov1,4 1 - Department of Pharmacology and Toxicology, University of Lausanne, 1005 Lausanne, Switzerland 2 - DNA Array Facility, University of Lausanne, 1015 Lausanne, Switzerland 3 - Service of Nephrology, Lausanne University Hospital, 1005 Lausanne, Switzerland 4 – these two authors have equally contributed to the study to whom correspondence should be addressed: Dmitri FIRSOV Department of Pharmacology and Toxicology, University of Lausanne, 27 rue du Bugnon, 1005 Lausanne, Switzerland Phone: ++ 41-216925406 Fax: ++ 41-216925355 e-mail: [email protected] and Olivier BONNY Department of Pharmacology and Toxicology, University of Lausanne, 27 rue du Bugnon, 1005 Lausanne, Switzerland Phone: ++ 41-216925417 Fax: ++ 41-216925355 e-mail: [email protected] 1 Abstract The distal parts of the renal tubule play a critical role in maintaining homeostasis of extracellular fluids. In this review, we present an in-depth analysis of microarray-based gene expression profiles available for microdissected mouse distal nephron segments, i.e., the distal convoluted tubule (DCT) and the connecting tubule (CNT), and for the cortical portion of the collecting duct (CCD) (Zuber et al., 2009). Classification of expressed transcripts in 14 major functional gene categories demonstrated that all principal proteins involved in maintaining of salt and water balance are represented by highly abundant transcripts. However, a significant number of transcripts belonging, for instance, to categories of G protein-coupled receptors (GPCR) or serine-threonine kinases exhibit high expression levels but remain unassigned to a specific renal function.
    [Show full text]
  • Epilepsy, Ataxia, Sensorineural Deafness
    SCO0010.1177/2050313X17723549SAGE Open Medical Case ReportsPapavasiliou et al. 723549case-report2017 SAGE Open Medical Case Reports Case Report SAGE Open Medical Case Reports Volume 5: 1 –6 Epilepsy, ataxia, sensorineural deafness, © The Author(s) 2017 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav tubulopathy syndrome in a European child https://doi.org/10.1177/2050313X17723549DOI: 10.1177/2050313X17723549 with KCNJ10 mutations: A case report journals.sagepub.com/home/sco Antigone Papavasiliou1, Katerina Foska1, John Ioannou1 and Mato Nagel2 Abstract Background: Epilepsy, ataxia, sensorineural deafness, tubulopathy syndrome is a multi-organ disorder that links to autosomal recessive mutations in the KCNJ10 gene, which encodes for the Kir4.1 potassium channel. It is mostly described in consanguineous, non-European families. Case Report: A European male of non-consanguineous birth, with early-onset, static ataxic motor disorder, intellectual disability and epilepsy, imitating cerebral palsy, presented with additional findings of renal tubulopathy, sensorineural deafness and normal neuroimaging leading to the diagnosis of epilepsy, ataxia, sensorineural deafness, tubulopathy syndrome. The patient was heterozygous for two KCNJ10 mutations: a missense mutation (p.R65C) that is already published and a not yet published duplication (p.F119GfsX25) that creates a premature truncation of the protein. Both mutations are likely damaging. Parental testing has not been performed, and therefore, we do not know for certain whether the mutations are on different alleles. This young man presents some clinical and laboratory features that differ from previously reported patients with epilepsy, ataxia, sensorineural deafness, tubulopathy syndrome. Conclusion: The necessity of accurate diagnosis through genetic testing in patients with static motor disorders resembling cerebral palsy phenotypes, atypical clinical features and noncontributory neuroimaging is emphasized.
    [Show full text]
  • Caveolin-1 Deficiency Inhibits the Basolateral K Channels in The
    BASIC RESEARCH www.jasn.org Caveolin-1 Deficiency Inhibits the Basolateral K+ Channels in the Distal Convoluted Tubule and Impairs Renal K+ and Mg2+ Transport † †‡ † † † Lijun Wang,* Chengbiao Zhang, Xiaotong Su, Dao-Hong Lin, and Wenhui Wang *Department of Physiology, Harbin Medical University, Harbin, China; †Department of Pharmacology, New York Medical College, Valhalla, New York; and ‡Jiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical College, Xuzhou, China ABSTRACT Kcnj10 encodes the inwardly rectifying K+ channel Kir4.1 in the basolateral membrane of the distal convoluted tubule (DCT) and is activated by c-Src. However, the regulation and function of this K+ channel are incompletely characterized. Here, patch-clamp experiments in Kcnj10-transfected HEK293 cells demonstrated that c-Src–induced stimulation of Kcnj10 requires coexpression of caveolin-1 (cav-1), and immunostaining showed expression of cav-1 in the basolateral membrane of parvalbumin-positive DCT. Patch-clamp experiments detected a 40-pS inwardly rectifying K+ channel, a heterotetramer of Kir4.1/Kir5.1, in the basolateral membrane of the early DCT (DCT1) in both wild-type (WT) and cav-1- knockout (KO) mice. However, the activity of this basolateral 40-pS K+ channel was lower in KO mice than in WT mice. Moreover, the K+ reversal potential (an indication of membrane potential) was less negative in theDCT1ofKOmicethanintheDCT1ofWTmice.Westernblotanalysisdemonstratedthatcav-1 – deficiency decreased the expression of the Na+/Cl cotransporter and Ste20-proline-alanine-rich kinase (SPAK) but increased the expression of epithelial Na+ channel-a. Furthermore, the urinary excretion of Mg2+ and K+ was significantly higher in KO mice than in WT mice, and KO mice developed hypomagne- semia, hypocalcemia, and hypokalemia.
    [Show full text]